688271.SH
联影医疗
SSE · Healthcare · Medical - Specialties · CN
CNY 105.40
−0.57%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 14.2B | 13.8B | 10.3B | 11.4B | 9.2B |
| Cost of Revenue | 7.6B | 7.3B | 5.3B | 6.0B | 4.8B |
| Gross Profit | 6.6B | 6.5B | 5.0B | 5.4B | 4.5B |
| Operating Expenses | |||||
| R&D Expense | 1.8B | 1.8B | 1.8B | 1.7B | 1.3B |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 633.5M | 626.9M | 556.0M | 560.7M | 430.6M |
| Selling & Marketing Expense | 2.3B | 2.3B | 1.8B | 1.6B | 1.3B |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 4.9B | 4.8B | 4.1B | 3.8B | 3.0B |
| Cost and Expenses | 12.5B | 12.1B | 9.4B | 9.9B | 7.8B |
| Operating Income (EBIT) | 2.1B | 2.0B | 1.4B | 2.1B | 1.9B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 2.1B | 2.0B | 1.4B | 2.1B | 1.9B |
| Income Tax Expense | 193.7M | 137.3M | 109.8M | 164.5M | 269.7M |
| Bottom Line | |||||
| Net Income | 1.9B | 1.9B | 1.3B | 2.0B | 1.7B |
| Earnings from Cont. Ops | 1.9B | 1.8B | 1.2B | 2.0B | 1.7B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 1.9B | 1.9B | 1.3B | 2.0B | 1.7B |
| Per Share | |||||
| Basic EPS | CN¥2.30 | CN¥2.28 | CN¥1.54 | CN¥2.40 | CN¥2.19 |
| Diluted EPS | CN¥2.30 | CN¥2.28 | CN¥1.54 | CN¥2.40 | CN¥2.19 |
| Revenue Per Share | CN¥17.12 | CN¥16.83 | CN¥12.57 | CN¥13.87 | CN¥12.22 |
| Shares | |||||
| Basic Shares Outstanding | 831.0M | 819.9M | 819.4M | 822.6M | 756.2M |
| Diluted Shares Outstanding | 831.0M | 819.9M | 819.4M | 822.6M | 756.2M |
| Profitability Metrics | |||||
| EBITDA | — | 2.5B | 1.8B | 2.5B | 2.2B |
| D&A | — | 516.4M | 391.6M | 325.9M | 272.7M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026